---
title: "EuroPCR 2024: Coronary implant with “site-specific” antithrombotic delivery shows promise at one year"
date: "2024-05-17T14:56:53.000Z"
publishedDate: "17 mai 2024"
summary: "Twelve-month outcomes from the DESyne BDS Plus trial, evaluating a novel triple drug-eluting coronary stent system, support the safety and efficacy of the platform to address ischaemic and bleeding risk in patients undergoing percutaneous coronary intervention (PCI), investigators have reported. DESyne BDS Plus (Elixir Medical) is a thin-strut stent system that uses sirolimus and two [&#8230;] The post EuroPCR 2024: Coronary implant with “site-specific” antithrombotic delivery shows promise at one year appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/europcr-2024-coronary-implant-with-site-specific-antithrombotic-delivery-shows-promise-at-one-year/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-05-17-europcr-2024-coronary-implant-with-site-specific-antithrombotic-delivery-shows-promise-at-one-year"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/IMG_9759_edited.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2024-coronary-implant-with-site-specific-antithrombotic-delivery-shows-promise-at-one-year/"
---

![EuroPCR 2024: Coronary implant with “site-specific” antithrombotic delivery shows promise at one year](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/IMG_9759_edited.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/europcr-2024-coronary-implant-with-site-specific-antithrombotic-delivery-shows-promise-at-one-year/*

## L’essentiel

Twelve-month outcomes from the DESyne BDS Plus trial, evaluating a novel triple drug-eluting coronary stent system, support the safety and efficacy of the platform to address ischaemic and bleeding risk in patients undergoing percutaneous coronary intervention (PCI), investigators have reported. DESyne BDS Plus (Elixir Medical) is a thin-strut stent system that uses sirolimus and two [&#8230;] The post EuroPCR 2024: Coronary implant with “site-specific” antithrombotic delivery shows promise at one year appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/europcr-2024-coronary-implant-with-site-specific-antithrombotic-delivery-shows-promise-at-one-year/
